Virus clearance validation across continuous capture chromatography. Issue 9 (27th May 2019)
- Record Type:
- Journal Article
- Title:
- Virus clearance validation across continuous capture chromatography. Issue 9 (27th May 2019)
- Main Title:
- Virus clearance validation across continuous capture chromatography
- Authors:
- Angelo, James
Chollangi, Srinivas
Müller‐Späth, Thomas
Jusyte, Simona
Xu, Xuankuo
Ghose, Sanchayita
Li, Zhengjian - Abstract:
- Abstract: Multicolumn capture chromatography is gaining increased attention lately due to the significant economic and process advantages it offers compared with traditional batch mode chromatography. However, for wide adoption of this technology in clinical and commercial space, it requires scalable models for executing viral validation studies. In this study, viral validation studies were conducted under cGLP guidelines to assess retro‐ (X‐MuLV) and parvo‐virus (MVM) clearance across twin‐column continuous capture chromatography (CaptureSMB). A surrogate model was also developed using standard batch mode chromatography based on flow path modifications to mimic the loading strategy used in CaptureSMB. The results show that a steady state was achieved by the second cycle for both antibody binding and virus clearance and that the surrogate model using batch mode chromatography equipment provided impurity clearance that was comparable to that obtained during cyclical operation of CaptureSMB. Further, the log reduction values (LRVs) achieved during CaptureSMB were also comparable to the LRVs obtained using standard batch capture chromatography. This was expected since the mode of virus separation during protein A chromatography is primarily based on removal during the flow through and wash steps. Finally, this study also presents assessments on the resin cleaning strategy during continuous chromatography and how the duration of clean‐in‐place solution exposure impacts virusAbstract: Multicolumn capture chromatography is gaining increased attention lately due to the significant economic and process advantages it offers compared with traditional batch mode chromatography. However, for wide adoption of this technology in clinical and commercial space, it requires scalable models for executing viral validation studies. In this study, viral validation studies were conducted under cGLP guidelines to assess retro‐ (X‐MuLV) and parvo‐virus (MVM) clearance across twin‐column continuous capture chromatography (CaptureSMB). A surrogate model was also developed using standard batch mode chromatography based on flow path modifications to mimic the loading strategy used in CaptureSMB. The results show that a steady state was achieved by the second cycle for both antibody binding and virus clearance and that the surrogate model using batch mode chromatography equipment provided impurity clearance that was comparable to that obtained during cyclical operation of CaptureSMB. Further, the log reduction values (LRVs) achieved during CaptureSMB were also comparable to the LRVs obtained using standard batch capture chromatography. This was expected since the mode of virus separation during protein A chromatography is primarily based on removal during the flow through and wash steps. Finally, this study also presents assessments on the resin cleaning strategy during continuous chromatography and how the duration of clean‐in‐place solution exposure impacts virus carryover. Abstract : Multicolumn capture chromatography is gaining increased attention lately due to the significant economic and process advantages it offers compared with traditional batch mode chromatography. However, for wide adoption of this technology in clinical and commercial space, it requires scalable models for executing viral validation studies. In this study, viral validation studies were conducted under cGLP guidelines to assess retro‐ (X‐MuLV) and parvo‐virus (MVM) clearance across twin‐column continuous capture chromatography (CaptureSMB). … (more)
- Is Part Of:
- Biotechnology and bioengineering. Volume 116:Issue 9(2019)
- Journal:
- Biotechnology and bioengineering
- Issue:
- Volume 116:Issue 9(2019)
- Issue Display:
- Volume 116, Issue 9 (2019)
- Year:
- 2019
- Volume:
- 116
- Issue:
- 9
- Issue Sort Value:
- 2019-0116-0009-0000
- Page Start:
- 2275
- Page End:
- 2284
- Publication Date:
- 2019-05-27
- Subjects:
- continuous chromatography -- MVM -- protein A -- viral carryover -- viral clearance -- X‐MuLV
Biotechnology -- Periodicals
Bioengineering -- Periodicals
660.6 - Journal URLs:
- http://onlinelibrary.wiley.com/doi/10.1002/bip.v101.5/issuetoc ↗
http://www.interscience.wiley.com ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/bit.27012 ↗
- Languages:
- English
- ISSNs:
- 0006-3592
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.850000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14250.xml